Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check12 days agoChange DetectedThe page now lists many new study locations and updated recruitment statuses, increasing the total locations to 73 and including new dates. This suggests broader site coverage and ongoing recruitment across more locations.SummaryDifference3%

- Check19 days agoChange DetectedRemoved a MedlinePlus Genetics topic on multiple myeloma, reducing genetics-related content on the page.SummaryDifference0.2%

- Check27 days agoChange DetectedVersion updated from v3.1.0 to v3.2.0 with an operational status notice and a new MedlinePlus Genetics topic on multiple myeloma.SummaryDifference3%

- Check34 days agoChange DetectedContent terms updated (Multiple myeloma replaces Plasma cell myeloma), new contact number added, and page revision updated to v3.1.0. Deletions remove the older terminology and the prior revision reference.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded new MedlinePlus Genetics topic: Multiple myeloma. This expands core content by introducing information about a specific disease.SummaryDifference0.2%

- Check48 days agoChange DetectedRecruitment status updated to Recruiting; new Barcelona site added and locations increased to 66; last update is now estimated and revision bumped to v3.0.2. Removed the related topic link for multiple myeloma.SummaryDifference1%

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.